TY - JOUR
T1 - Heterogeneity of clinical severity and molecular lesions in Aircardi syndrome
AU - Neidich, Julie A.
AU - Nussbaum, Robert L.
AU - Packer, Roger J.
AU - Emanuel, Beverly S.
AU - Puck, Jennifer M.
N1 - Funding Information:
Aicardi syndrome was originally described in 15 female patients who had mental retardation, infantile spasms, agenesis of the corpus callosum, and a pathognomonic chorioretinal abnormality called lacunae.i, 2 These discrete, yellow, sharp-bordered defects in the choroid can be as large as the optic disc and are present at birth. 2, 3 Because all reported patients are female 4 or have a 47,XXY karyotype, 5 Supported by National Institutes of Health training grants, Nos. HD07101, R01-HD23679, and BRSG RR-054 l 5, by the Howard Hughes Medical Institute, and by funds from the Allen H. and Selma W. Berkman Charitable Trust for the Aicardi Syndrome Project in memory of Beth Joanna Habbert. Submitted for publication Nov. 1, 1989; accepted Jan. 12, 1990. Reprint requests: Julie Ann Neidich, MD, Division of Human Genetics, Department of Pediatrics, New York Hospital/Cornell University Medical Center, 525 East 68th St., New York, NY 10021. 9/20/19414 it has been suggested that Aicardi syndrome is due to a dominant mutation on the X chromosome that is lethal in males with only one X chromosome and causes disease in females with two X chromosomes. 4 However, it is difficult to prove that Aicardi syndrome is caused by an X-linked dominant genetic lesion with male
PY - 1990/6
Y1 - 1990/6
N2 - All patients with Aicardi syndrome are female or have a 47,XXY karyotype. This finding, along with a report of an Aicardi syndrome patient with an Xp22/autosome translocation, led to the hypothesis that Aicardi syndrome might be caused by an X-linked dominant, male-lethal mutation on the short arm of the X chromosome. To study this hypothesis, we investigated X chromosome inactivation patterns in peripheral lymphocytes from seven patients. We used two methods: methylation-sensitive restriction enzyme analysis and segregation of the active X chromosome in somatic cell hybrids. We found that three of seven cytogenetically normal girls with Aicardi syndrome had profoundly skewed X-inactivation in their lymphocytes, supporting the concept that Aicardi syndrome is X linked. Three of the five girls with the greatest degree of psychomotor retardation and the poorest seizure control had skewed X-inactivation. In contrast, the two highest-functioning children had random X-inactivation. We screened DNA using eight polymorphic probes from the Xp22 region but were unable to identify a deletion in any of the seven patients. Nonrandom X-inactivation in lymphocytes and possibly other tissues in some, but not all, patients with Aicardi syndrome may reflect heterogeneity of their molecular lesions.
AB - All patients with Aicardi syndrome are female or have a 47,XXY karyotype. This finding, along with a report of an Aicardi syndrome patient with an Xp22/autosome translocation, led to the hypothesis that Aicardi syndrome might be caused by an X-linked dominant, male-lethal mutation on the short arm of the X chromosome. To study this hypothesis, we investigated X chromosome inactivation patterns in peripheral lymphocytes from seven patients. We used two methods: methylation-sensitive restriction enzyme analysis and segregation of the active X chromosome in somatic cell hybrids. We found that three of seven cytogenetically normal girls with Aicardi syndrome had profoundly skewed X-inactivation in their lymphocytes, supporting the concept that Aicardi syndrome is X linked. Three of the five girls with the greatest degree of psychomotor retardation and the poorest seizure control had skewed X-inactivation. In contrast, the two highest-functioning children had random X-inactivation. We screened DNA using eight polymorphic probes from the Xp22 region but were unable to identify a deletion in any of the seven patients. Nonrandom X-inactivation in lymphocytes and possibly other tissues in some, but not all, patients with Aicardi syndrome may reflect heterogeneity of their molecular lesions.
UR - http://www.scopus.com/inward/record.url?scp=0025314194&partnerID=8YFLogxK
U2 - 10.1016/S0022-3476(05)80649-3
DO - 10.1016/S0022-3476(05)80649-3
M3 - Article
C2 - 1971852
AN - SCOPUS:0025314194
SN - 0022-3476
VL - 116
SP - 911
EP - 917
JO - Journal of Pediatrics
JF - Journal of Pediatrics
IS - 6
ER -